Finally, after deciphering the molecular and physiological details of the two signaling pathway the third venue will be translational, to design a molecule that can target directly the catalytic domain and bring ANF-RGC to its full activity and prevent the pandemic of hypertension, myocardial hypertrophy and obesity. This evidence concerns the gene NPPA and hypertensive disorder.